Fresh Tracks Therapeutics Inc
General ticker "FRTX" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $5.0M
Fresh Tracks Therapeutics Inc does not follow the US Stock Market performance with the rate: -26.1%.
Estimated limits based on current volatility of 1.4%: low 0.92$, high 0.94$
Factors to consider:
- Company does not operate outside North America (retrieved using AI)
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [0.49$, 1.75$]
- 2024-12-30 to 2025-12-30 estimated range: [0.66$, 2.06$]
Financial Metrics affecting the FRTX estimates:
- Negative: Non-GAAP EPS, $ of -1.41 <= 0.03
- Negative: 0 < Interest expense per share, $ of 0
- Positive: Inventory ratio change, % of -6.77 <= -1.09
- Negative: Industry operating cash flow per share per price (median), % of -22.73 <= 2.82
- Negative: -0.37 < Industry inventory ratio change (median), % of 0
- Negative: negative Operating income
- Negative: negative Net income
Short-term FRTX quotes
Long-term FRTX plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.40MM | $6.94MM | $8.01MM |
| Operating Expenses | $40.65MM | $28.48MM | $14.37MM |
| Operating Income | $-40.24MM | $-21.53MM | $-6.36MM |
| Non-Operating Income | $0.77MM | $0.43MM | $0.67MM |
| Interest Expense | $0.07MM | $0.01MM | $0.01MM |
| R&D Expense | $28.23MM | $14.04MM | $3.18MM |
| Income(Loss) | $-39.47MM | $-21.10MM | $-5.69MM |
| Profit(Loss)* | $-39.52MM | $-20.66MM | $-5.69MM |
| Stockholders Equity | $24.91MM | $7.19MM | $9.93MM |
| Inventory | $0.12MM | $0.50MM | $0.00MM |
| Assets | $29.72MM | $10.27MM | $11.59MM |
| Operating Cash Flow | $-36.15MM | $-19.34MM | $-4.34MM |
| Capital expenditure | $0.04MM | $0.05MM | $0.00MM |
| Investing Cash Flow | $-0.04MM | $-0.05MM | $0.00MM |
| Financing Cash Flow | $32.95MM | $1.18MM | $6.53MM |
| Earnings Per Share** | $-22.14 | $-7.36 | $-0.96 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.